FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 26,610,964
- Share change
- +1,595,714
- Total reported value
- $86,219,950
- Price per share
- $3.24
- Number of holders
- 57
- Value change
- +$4,849,002
- Number of buys
- 36
- Number of sells
- 24
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC |
13F
|
Company |
5%
|
6,076,879
|
$27,650,000 | — | 31 Mar 2017 | |
| FMR LLC |
13F
|
Company |
3.6%
|
4,391,885
|
$19,983,000 | — | 31 Mar 2017 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.1%
|
2,537,026
|
$11,543,000 | — | 31 Mar 2017 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
2%
|
2,473,186
|
$11,253,000 | — | 31 Mar 2017 | |
| BVF INC/IL |
13F
|
Company |
1.6%
|
1,945,245
|
$8,851,000 | — | 31 Mar 2017 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.4%
|
1,711,958
|
$7,789,000 | — | 31 Mar 2017 | |
| Redmile Group, LLC |
13F
|
Company |
1.2%
|
1,419,058
|
$6,457,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.94%
|
1,155,679
|
$5,258,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.5%
|
611,646
|
$2,783,000 | — | 31 Mar 2017 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.38%
|
470,000
|
$2,139,000 | — | 31 Mar 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.24%
|
295,700
|
$1,345,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.23%
|
281,111
|
$1,279,000 | — | 31 Mar 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
250,000
|
$1,138,000 | — | 31 Mar 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.16%
|
195,928
|
$891,000 | — | 31 Mar 2017 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.12%
|
150,000
|
$682,000 | — | 31 Mar 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
144,053
|
$655,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
119,514
|
$543,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
86,289
|
$392,000 | — | 31 Mar 2017 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.06%
|
68,600
|
$312,000 | — | 31 Mar 2017 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.05%
|
60,704
|
$276,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
59,510
|
$271,000 | — | 31 Mar 2017 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.04%
|
54,598
|
$248,000 | — | 31 Mar 2017 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.03%
|
41,300
|
$188,000 | — | 31 Mar 2017 | |
| Segantii Capital Management Ltd |
13F
|
Company |
0.03%
|
39,999
|
$182,000 | — | 31 Mar 2017 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
0.03%
|
35,200
|
$160,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
34,455
|
$157,000 | — | 31 Mar 2017 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
31,790
|
$145,000 | — | 31 Mar 2017 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
29,510
|
$134,000 | — | 31 Mar 2017 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
28,900
|
$131,000 | — | 31 Mar 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
25,143
|
$115,000 | — | 31 Mar 2017 | |
| Virtu KCG Holdings LLC |
13F
|
Company |
0.02%
|
24,480
|
$111,000 | — | 31 Mar 2017 | |
| Creative Planning |
13F
|
Company |
0.02%
|
23,000
|
$105,000 | — | 31 Mar 2017 | |
| Dynamic Technology Lab Private Ltd |
13F
|
Company |
0.02%
|
21,654
|
$99,000 | — | 31 Mar 2017 | |
| GLG Partners LP |
13F
|
Company |
0.02%
|
20,754
|
$94,000 | — | 31 Mar 2017 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.01%
|
17,728
|
$81,000 | — | 31 Mar 2017 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.01%
|
15,000
|
$68,000 | — | 31 Mar 2017 | |
| Cerity Partners LLC |
13F
|
Company |
0.01%
|
13,920
|
$63,000 | — | 31 Mar 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
13,746
|
$63,000 | — | 31 Mar 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.01%
|
12,465
|
$57,000 | — | 31 Mar 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
12,372
|
$56,000 | — | 31 Mar 2017 | |
| Acrospire Investment Management LLC |
13F
|
Company |
0.01%
|
8,822
|
$40,000 | — | 31 Mar 2017 | |
| Community Bank, N.A. |
13F
|
Company |
0.01%
|
6,500
|
$30,000 | — | 31 Mar 2017 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
5,400
|
$25,000 | — | 31 Mar 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,166
|
$10,000 | — | 31 Mar 2017 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
2,000
|
$9,000 | — | 31 Mar 2017 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
1,250
|
$5,000 | — | 31 Mar 2017 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
1,170
|
$5,000 | — | 31 Mar 2017 | |
| Vigilant Capital Management, LLC |
13F
|
Company |
0%
|
1,000
|
$5,000 | — | 31 Mar 2017 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0%
|
720
|
$3,000 | — | 31 Mar 2017 | |
| TCI Wealth Advisors, Inc. |
13F
|
Company |
0%
|
500
|
$2,000 | — | 31 Mar 2017 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2017
As of 30 Jun 2017,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,610,964 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, EcoR1 Capital, LLC, Polaris Venture Management Co. V, L.L.C., BlackRock Inc., Redmile Group, LLC, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., MORGAN STANLEY, and 683 Capital Management, LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
51
Q2 2017 holders
57
Holder diff
6
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.